ASST Strive, Inc. (NASDAQ) -$0.13 to $0.97 pre-market 14 Jan 2026: 361,951,195 shares traded, watch technical setup

ASST stock is trading at $0.97 pre-market on 14 Jan 2026 after a -11.82% one-day decline that followed an intraday high of $1.17 and low of $0.89. Volume is heavy at 361,951,195 shares versus an average of 115,970,337, marking ASST among the NASDAQ most active names in early U.S. trading. The move comes ahead of a scheduled earnings announcement on 25 Feb 2026 and after recent strategic actions, including the Semler Scientific acquisition approval. We examine price drivers, valuation, technicals and what active traders should watch in the pre-market session.

Pre-market price action for ASST stock

ASST opened at $1.15 and is quoted at $0.97 pre-market on 14 Jan 2026, down $0.13 or -11.82% from the prior close of $1.10. Intraday range was $0.89 to $1.17; the relative volume is 3.11x, highlighting unusually high trading interest. This volume surge places ASST on the NASDAQ most active list and increases the chance of larger intraday swings in USD.

Fundamental snapshot and valuation for ASST stock

Strive, Inc. (ASST) is listed on NASDAQ and operates in Communication Services, with core activity tied to social media marketing and asset management. Market capitalization is approximately $650.87 million with 670,999,200 shares outstanding. The company reports EPS of -0.04 and a negative PE (reported -24.25), while price-to-book is 0.00 (PB 0.0028), reflecting a balance-sheet heavy profile and elevated valuation ratios like P/S at 422.78. These metrics show distortions from low share price and large book value per share (book value per share 350.18 USD).

Technical signals and trading setup for ASST stock

Short-term indicators show mixed momentum: RSI 56.01 and MACD histogram 0.04 suggest neutral to slightly bullish pressure despite the pre-market drop. Bollinger band middle is $0.88 with upper $1.06 and lower $0.69, which positions current price near the middle band and within normal volatility (ATR 0.11). Traders should watch support near the day low $0.89 and resistance at prior intraday high $1.17 for scalps and stop placement in USD.

Meyka AI rates ASST with a proprietary grade and forecast

Meyka AI rates ASST with a score of 58.56 out of 100 — Grade C+ and suggestion: HOLD. This grade factors S&P 500 benchmark comparison, sector and industry comparisons, financial growth, key metrics, forecasts, analyst consensus and fundamental growth. Meyka AI’s forecast model projects a yearly price of $3.64 USD, implying an upside of 275.26% from the current $0.97; monthly model projection is $1.13 USD (≈16.49% upside). Forecasts are model-based projections and not guarantees. These grades are not guaranteed and we are not financial advisors.

Catalysts, recent news and analyst context for ASST stock

Recent developments include shareholder approval for the Semler Scientific acquisition and insider buying by CEO Matthew Ryan Cole, which market reports flagged as notable. Analysts show mixed sentiment: Maxim Group set a $1.50 target and MarketBeat lists a consensus price target of $1.50 USD; coverage is sparse and floating. For source context see market reports on Investing.com and the MarketBeat summary on the gap up on 13 Jan 2026 MarketBeat.

Trading implications and why ASST is ‘most active’ pre-market

High relative volume (3.11x) and wide historical weekly range mean ASST attracts momentum and short-term traders in the United States NASDAQ session. Given the low current price and heavy share count, price moves can be large in percentage terms while USD moves remain small. Active traders should size positions for volatility, track intraday VWAP, and watch the 50-day average at $1.04 and the 200-day average at $3.20 for trend context.

Final Thoughts

Key takeaways: ASST stock is trading $0.97 USD pre-market on 14 Jan 2026 after an -11.82% drop on exceptionally heavy 361,951,195 volume, putting it among the NASDAQ most active names. Fundamentals show a distorted valuation mix: negative EPS -0.04, very high P/S 422.78, and large book value per share 350.18 USD, which together drive divergent analyst views and the current Meyka AI Grade C+ (HOLD). Meyka AI’s forecast model projects a yearly price of $3.64 USD, an implied upside of 275.26%, and a nearer-term monthly projection of $1.13 USD (≈16.49% upside). Traders and investors should weigh active pre-market liquidity, upcoming earnings on 25 Feb 2026, recent corporate moves such as the Semler deal, and the stretched technical indicators. For short-term trading, prioritize risk controls and liquidity. For longer-term assessment, await clearer earnings and operational updates before increasing exposure. Meyka AI provides this AI-powered market analysis platform insight as one data point among many; forecasts are projections, not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.